Seven large employers, including six Fortune 500 companies and one state, have launched Catalyst for Payment Reform (CPR
Seven large employers, including six Fortune 500 companies and one state, have launched Catalyst for Payment Reform (CPR). CPR is an effort to help large employers work together to accelerate healthcare payment reforms.
The employers who have signed onto CPR are The Boeing Company, Delta Air Lines, Equity Healthcare, GE, the Group Insurance Commission of the Commonwealth of Massachusetts, Intel Corporation, and Wal-Mart Stores, Inc.
CPR plans to provide them with tools to assess the attributes of specific markets to determine how various reforms to payment can be most effective in those locations, and will track progress on payment reform.
“There is a lot more work that needs to be done on this front, requiring much more transparency from health plans to providers,” says Suzanne Delbanco, Ph.D., who is CPR’s executive director. “We need to create the equivalent of a bank statement for physicians and hospitals to clarify where their money comes from, how much, and why. Ideally, payment contracts will instantly align incentives for higher-quality and more cost-effective care. But as long as we are combining normal fee schedules with incentives, distinguishing the portions of each is critical to motivate behavior change.”
CPR’s plans to release tools throughout this fall, including the Market Assessment Tool and six Action Briefs that outline steps employers can take toward three types of payment reform (fee for service, bundled payments, and global payments), two types of delivery system reform (accountable care organizations and medical homes), and analyses of how the level of competition in a given market affects the rates at which purchasers and plans pay providers.
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More